Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 21:1-12. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly ...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 21:1-15. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational o...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 21:1-12. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly ...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 21:1-15. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational o...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 21:1-12. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly ...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 21:1-15. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational o...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 21:1-12. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly ...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 21:1-15. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational o...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: Expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly avail...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational organi...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: Expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly avail...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational organi...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: Expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly avail...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research

Diagnosis and management of pulmonary veno-occlusive disease
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247989. Online ahead of print.ABSTRACTINTRODUCTION: Pulmonary veno-occlusive disease (PVOD) is an orphan disease and uncommon etiology of pulmonary arterial hypertension (PAH) characterized by substantial small pulmonary vein and capillary involvement.AREAS COVERED: PVOD, also known as 'PAH with features of venous/capillary involvement' in the current ESC/ERS classification.EXPERT OPINION: In recent years, particular risk factors for PVOD have been recognized, including genetic susceptibilities and environmental factors (such as exposure to occupational organi...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Sabina Solinas Ath énaïs Boucly Antoine Beurnier Mithum Kularatne Julien Grynblat M élanie Eyries Peter Dorfm üller Olivier Sitbon Marc Humbert David Montani Source Type: research

Evaluating as-needed inhaled corticosteroid strategies in asthma: Expanding the benefits to mild asthma
Expert Rev Respir Med. 2023 Aug 14. doi: 10.1080/17476348.2023.2247973. Online ahead of print.ABSTRACTINTRODUCTION: Adherence to regular anti-inflammatory treatment is commonly low, and short-acting β2 agonist (SABA) overuse is common in patients with asthma, leading to an increased risk of asthma-related adverse events.AREAS COVERED: Given the pivotal role of inflammation in asthma, multiple as-needed inhaled corticosteroid (ICS)-containing therapies have been developed, leading to a reduction in asthma exacerbations and improvement in symptom control. Currently, as-needed ICS/formoterol is one of the most commonly avail...
Source: Expert Review of Respiratory Medicine - August 14, 2023 Category: Respiratory Medicine Authors: Tommaso Bigoni Franco Alfano Federico Baraldi Marco Contoli Alberto Papi Source Type: research